You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
As part of a restructuring and cost reduction plan the firm also reduced the principle of its 2016 convertible note by about half.
The moves are part of an effort to consolidate and reduce costs related to administrative, finance, and operational support functions.
The company beat analysts' consensus estimates on both the top and bottom lines as its molecular diagnostics sales rose 9 percent at constant exchange rates.
The company said the diagnostics unit will be focused on reproductive health, diagnostics for emerging markets, and applied genomics.